Hospices Civils de Lyon, Louis Pradel Hospital, National Reference Centre for Rare Pulmonary Diseases, Department of Respiratory Medicine, University Claude Bernard Lyon I, University of Lyon, Lyon, France.
Semin Respir Crit Care Med. 2012 Oct;33(5):462-75. doi: 10.1055/s-0032-1325157. Epub 2012 Sep 21.
Organizing pneumonia (OP) is a pathological pattern defined by the characteristic presence of buds of granulation tissue within the lumen of distal pulmonary airspaces consisting of fibroblasts and myofibroblasts intermixed with loose connective matrix. This pattern is the hallmark of a clinical pathological entity, namely cryptogenic organizing pneumonia (COP) when no cause or etiologic context is found. The process of intraalveolar organization results from a sequence of alveolar injury, alveolar deposition of fibrin, and colonization of fibrin with proliferating fibroblasts. A tremendous challenge for research is represented by the analysis of features that differentiate the reversible process of OP from that of fibroblastic foci driving irreversible fibrosis in usual interstitial pneumonia because they may determine the different outcomes of COP and idiopathic pulmonary fibrosis (IPF), respectively. Three main imaging patterns of COP have been described: (1) multiple patchy alveolar opacities (typical pattern), (2) solitary focal nodule or mass (focal pattern), and (3) diffuse infiltrative opacities, although several other uncommon patterns have been reported, especially the reversed halo sign (atoll sign). Definitive diagnosis is based on (1) a suggestive clinical radiological presentation, (2) the demonstration of the characteristic pathological pattern at lung histopathology, and (3) exclusion of possible causes. Transbronchial biopsies or a transthoracic biopsy may also contribute to the pathological diagnosis. Rapid clinical and imaging improvement is obtained with corticosteroid therapy. Because of the risk of misdiagnosing alternative conditions that may mimic OP, only typical cases may be managed without histopathological confirmation, and patients should be followed with particular attention paid to any clue of alternate diagnosis, especially in case of incomplete response to treatment. Patients and clinicians must be aware of frequent relapses after stopping corticosteroid treatment.
机化性肺炎(OP)是一种病理学模式,其特征为在远端肺空气腔的管腔内存在肉芽组织芽,由成纤维细胞和肌成纤维细胞与疏松结缔基质混合而成。当未发现任何原因或病因背景时,这种模式是一种临床病理实体,即特发性机化性肺炎(COP)的标志。肺泡内组织化的过程源自肺泡损伤、肺泡内纤维蛋白沉积以及纤维蛋白上增殖的成纤维细胞定植的一系列过程。COP 的可逆过程与寻常型间质性肺炎中驱动不可逆纤维化的成纤维细胞灶之间的区别特征的分析对研究来说是一个巨大的挑战,因为它们可能分别决定了 COP 和特发性肺纤维化(IPF)的不同结局。COP 有三种主要的影像学模式:(1)多发斑片状肺泡混浊(典型模式),(2)单发局灶性结节或肿块(局灶模式)和(3)弥漫性浸润性混浊,尽管已经报道了几种其他不常见的模式,特别是反转晕征(环礁征)。明确诊断基于(1)提示性的临床放射学表现,(2)在肺组织病理学上显示出特征性的病理模式,以及(3)排除可能的原因。经支气管活检或经胸活检也可能有助于病理诊断。皮质类固醇治疗可迅速改善临床和影像学表现。由于存在误诊为可能模拟 OP 的其他疾病的风险,只有典型病例可以在没有组织病理学证实的情况下进行管理,并且应特别注意任何替代诊断的线索,尤其是在治疗反应不完全的情况下。患者和临床医生必须意识到在停止皮质类固醇治疗后经常会复发。
Semin Respir Crit Care Med. 2012-9-21
Semin Respir Crit Care Med. 2000
Ter Arkh. 2012
Rev Mal Respir. 2010-5
Clin Chest Med. 2004-12
Respir Med. 2000-7
Semin Respir Crit Care Med. 2003-10
J Assoc Physicians India. 2015-7
Eur Respir J. 2006-8
J Community Hosp Intern Med Perspect. 2025-1-6
Respirol Case Rep. 2025-1-4
J Thorac Dis. 2024-5-31